Timmerman Report

@timmermanreport

Timmerman Report is an independently-owned biotech news and analysis publication. Subscribe today!

Seattle
Vrijeme pridruživanja: siječanj 2015.

Tweetovi

Blokirali ste korisnika/cu @timmermanreport

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @timmermanreport

  1. Curious about Verana Health's plan to extract meaning from EHRs to become like Flatiron, but for ophthalmology? Verana raised $100m today. TR subscribers got ahead of the curve, reading about it back in July 2018. (See archives)

    Poništi
  2. First Buy, Then Invest: Novartis, Kite/Gilead join $35m Bet on Vineti software for cell & gene therapy. (Subscription Required).

    Poništi
  3. 2. velj

    Started 5 years ago today. Thanks to all of you, the subscribers, who make it possible.

    Poništi
  4. 30. sij

    Original TR story on Black Diamond Therapeutics from when it came out of stealth, Dec. 2018. (Subscription Required). IPO+80% today. . Subscribe today and get more forward-looking stories like this.

    Poništi
  5. 27. sij

    Challenging core assumptions, today's tech critics can help us all craft a better healthtech future, says .

    Poništi
  6. 23. sij

    False Heroes: Read book excerpt, in which he demolishes PBMs and their perverse incentives for high drug pricing.

    Poništi
  7. 22. sij

    Seeking to Understand Dr. King's Vision of Unity, in Our Divided Times. By founder/chairman of

    Poništi
  8. 10. sij

    Save yourself some time, get a fresh perspective, and absorb the main events of the week before . Read the Frontpoints column. Fridays on TR. (Sub. Req.)

    Poništi
  9. 10. sij

    I'm really enjoying editing health tech columns by . Adds a new dimension to TR for 2020. Another good reason to subscribe today-->

    Poništi
  10. 9. sij

    Sanofi's new CEO is bringing a grounded view to healthtech. By TR columnist

    Poništi
  11. proslijedio/la je Tweet
    7. sij

    Great new Long Run podcast on David Baker and : Proud to be a sponsor

    Poništi
  12. proslijedio/la je Tweet
    7. sij

    Neglected Common Diseases are a huge source of human suffering. How can we do a better job of addressing them? Learnings from orphan diseases in my article for (subscription required).

    Poništi
  13. 6. sij

    Three Lessons for Business, and Life, Ahead of . By , reflecting on her Kilimanjaro experience. (Free, shareable post).

    Poništi
  14. 2. pro 2019.

    Welcome -- new sponsor of The Long Run podcast. Listen to what they can do for your drug development in the next episode!

    Poništi
  15. 2. pro 2019.

    So much to be thankful for this holiday season. How about the team at TR? Pedro Rosado Steve White, and Stephanie Barnes. Bios -->

    Poništi
  16. 2. pro 2019.

    IFM, Staying Small, Raises (Merely) $55.5m, Promotes Former Novartis Exec to CEO. (TR Subscription Required).

    Poništi
  17. 22. stu 2019.

    AI Can Help With Repeatable Processes, But Don't Expect Thunderbolts for Drug Discovery. By (free, shareable, no ads)

    Poništi
  18. 20. stu 2019.

    Meet Stephanie Barnes, business rep for TR. She can help with sponsorships of The Long Run podcast, group subscriptions to TR, speaking requests and more. Excited to have her on the team!

    Poništi
  19. 19. stu 2019.

    Excited about today's and news? wrote 2 weeks ago about why hemoglobinopathies have emerged as gene editing indications. Subscribe to TR and get ahead of the curve!

    Poništi
  20. 19. stu 2019.

    Feeding Frenzy: The Biotech Ocean has a Lot More Than Just Sardines and Whales, and That's Good. Guest article by Clay Thorp & Ben Scruggs of Hatteras Venture Partners. (Sub. Req.)

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·